Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 81 - 100 out of 500 displayed.
«  1  2  3  4 5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

Aanastra Inc to Showcase its Peptide-RNA Therapeutics Technology in Multiple Presentations at the American Society for Gene and Cell Therapies (ASGCT) Annual Meeting 2024

Read more ››
By: GlobeNewswire - 02 May 2024

SpringWorks Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Business Updates

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  SpringWorks Therapeutics Inc.

Regeneron Reports First Quarter 2024 Financial and Operating Results

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Regeneron Pharmaceuticals Inc.

Reunion Neuroscience Inc. Announces $103 Million Series A Financing Co-Led by MPM BioImpact and Novo Holdings

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Reunion Neuroscience Inc.

Axogen, Inc Reports First Quarter 2024 Financial Results

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  AxoGen, Inc.

Arvinas to Present at Upcoming Investor Conferences

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Arvinas, Inc.

Pneumagen to Present Phase 2 Clinical Data on Neumifil, its Broad-Spectrum Antiviral, Intranasal Drug for Viral Respiratory Tract Infections, at ATS 2024

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Pneumagen Ltd

Quell Therapeutics Highlights Clinical Potential of QEL-001 and its Multi-Modular Treg Cell Therapy Platform at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Quell Therapeutics Ltd

BridgeBio launches BridgeBio Oncology Therapeutics (BBOT) with $200M of private external capital to accelerate the development of its novel precision oncology pipeline

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  BridgeBio Pharma, Inc.

Athira Pharma to Participate in Upcoming May Conferences

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Athira Pharma, Inc.

Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee Osteoarthritis

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Organogenesis Holdings Inc.

Chemomab Therapeutics to Present at 2024 Aegis Virtual Conference

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Chemomab Therapeutics Ltd.

Tilray Brands Launches XMG Zero, a New ‘Better for You’ Cannabis Beverage

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Tilray Inc.

ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  ADMA Biologics, Inc.

Krystal Biotech to Present at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Krystal Biotech, Inc.

Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Pluri Inc.

Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor Events

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Editas Medicine, Inc.

Agios Reports Business Highlights and First Quarter 2024 Financial Results

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Agios Pharmaceuticals, Inc.

Matinas BioPharma to Webcast Conference Call to Discuss First Quarter 2024 Financial Results and Provide a Business Update on May 9, 2024

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Matinas BioPharma Holdings Inc.

Kymera Therapeutics Announces First Quarter 2024 Financial Results and Provides a Business Update

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Kymera Therapeutics Inc.
«  1  2  3  4 5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑